Document Detail

Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe?
MedLine Citation:
PMID:  19371188     Owner:  NLM     Status:  MEDLINE    
Primary- and secondary-prevention trials involving subjects with or at risk for coronary artery disease have previously demonstrated a beneficial effect of conventional-dose statin therapy. Recent trials of high-dose statin therapy in subjects with stable coronary disease or acute coronary syndromes have yielded conflicting results. The aim of this narrative article is to provide a critical and up-to-date summary of the findings of clinical trials of intensive statin therapy, including a brief overview of the safety and efficacy of such treatments.
Sreenivasa R K Seshasai; Kausik K Ray
Related Documents :
19371188 - Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe?
3383468 - Effect of aging on doppler echocardiographic filling parameters in normal subjects and ...
11016388 - Wrist-enhanced instrumentation: moving toward totally endoscopic coronary artery bypass...
2345318 - Newer surgical techniques in myocardial revascularization.
177168 - Pulmonary tumorlet. a form of peripheral carcinoid.
8974818 - Implantation of the peripheral wallstent for diffuse lesions in coronary arteries and v...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Future cardiology     Volume:  5     ISSN:  1744-8298     ISO Abbreviation:  Future Cardiol     Publication Date:  2009 Mar 
Date Detail:
Created Date:  2009-04-17     Completed Date:  2009-07-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101239345     Medline TA:  Future Cardiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  129-39     Citation Subset:  IM    
Molecular Epidemiology Unit, Strangeways Research Laboratory, Worts Causeway, Cambridge, CB1 8RN, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cholesterol / blood*
Coronary Artery Disease / blood,  drug therapy*
Dose-Response Relationship, Drug
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage,  therapeutic use*
Treatment Outcome
Reg. No./Substance:
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Noninvasive assessment of myocardial ischemia in the future: fusion of anatomical and functional ima...
Next Document:  Drug-eluting stents: a comprehensive appraisal.